Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Systemic <i>In Silico</i> Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server

Chi XuLaboratory of Health Intelligence, Huawei Technologies Co., Ltd, Shenzhen 518100, ChinaZunhui KeWuhan Children’s Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430000, ChinaChuandong LiuCollege of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, 100049 ChinaZhihao WangBioBank, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi 710061, ChinaDenghui LiuLaboratory of Health Intelligence, Huawei Technologies Co., Ltd, Shenzhen 518100, ChinaLei ZhangLaboratory of Health Intelligence, Huawei Technologies Co., Ltd, Shenzhen 518100, ChinaJingning WangDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaWenjun HeLaboratory of Health Intelligence, Huawei Technologies Co., Ltd, Shenzhen 518100, ChinaZhimeng XuLaboratory of Health Intelligence, Huawei Technologies Co., Ltd, Shenzhen 518100, ChinaYanqing LiBioBank, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi 710061, ChinaYanan YangBioBank, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi 710061, ChinaZhaowei HuangLaboratory of Health Intelligence, Huawei Technologies Co., Ltd, Shenzhen 518100, ChinaPanjing LvDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaXin WangBioBank, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi 710061, ChinaDali HanChina National Center for Bioinformation, Beijing 100101, ChinaYan LiBioBank, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi 710061, ChinaNan QiaoLaboratory of Health Intelligence, Huawei Technologies Co., Ltd, Shenzhen 518100, ChinaBing LiuBioBank, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi 710061, China
2020en
ABI

Аннотация

The emergence of the new coronavirus (nCoV-19) has impacted human health on a global scale, while the interaction between the virus and the host is the foundation of the disease. The viral genome codes a cluster of proteins, each with a unique function in the event of host invasion or viral development. Under the current adverse situation, we employ virtual screening tools in searching for drugs and natural products which have been already deposited in DrugBank in an attempt to accelerate the drug discovery process. This study provides an initial evaluation of current drug candidates from various reports using our systemic in silico drug screening based on structures of viral proteins and human ACE2 receptor. Additionally, we have built an interactive online platform (https://shennongproject.ai/) for browsing these results with the visual display of a small molecule docked on its potential target protein, without installing any specialized structural software. With continuous maintenance and incorporation of data from laboratory work, it may serve not only as the assessment tool for the new drug discovery but also an educational web site for the public.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 3Использованных источников: 0